In our work, we also showed that the overexpression of SOX9 in two pancreatic cancer cell lines, BxPC-3 and Colo357, results in increased cell proliferative activity and decreased CDKN1A expression levels. This evidence concerns the gene CDKN1A and pancreatic neoplasm.